Probiotic-induced changes in intestinal microbiome inhibits Toxoplasma gondii infection
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Toxoplasma gondii primarily invades the central nervous system, causing latent infections. Cysts persist in the host for life and there is currently no effective treatment. T. gondii infects human hosts through contaminated meat, invading the intestinal tissue and leading to changes in the number and composition of the gut microbiota. Since probiotic ingestion modulates intestinal microbiota changes, we hypothesized that intestinal microbiota dysbiosis caused by T. gondii infection would be restored following probiotic supplementation. To this end, we orally infected C57BL/6 mice with 10 T. gondii cysts and administered supplemental probiotics daily. We analyzed the levels of T. gondii B1 gene DNA, indicative of T. gondii infection, in brain tissue. We investigated alterations in the gut microbiota composition and functional pathways between the probiotic and non-probiotic treatment groups via next-generation sequencing analysis of each fecal sample. The infection level in the probiotic-treated group was significantly reduced after 4 weeks (P<0.05). Probiotic supplementation notably changed the gut microbiota after 2 weeks of infection, increasing the relative abundance of Intestinimonas massiliensis and Lawsonibacter asaccharolyticus. Probiotic supplements appear to modulate the gut microbiota, activating functional pathways involved in intestinal short-chain fatty acid production and strengthening the intestinal barrier, thereby impeding T. gondii infection and subsequent proliferation. Our findings provide valuable insights into T. gondii infection control and future study directions.
Abstract
Toxoplasma gondii primarily invades the central nervous system, causing latent infections. Cysts persist in the host for life and there is currently no effective treatment. T. gondii infects human hosts through contaminated meat, invading the intestinal tissue and leading to changes in the number and composition of the gut microbiota. Since probiotic ingestion modulates intestinal microbiota changes, we hypothesized that intestinal microbiota dysbiosis caused by T. gondii infection would be restored following probiotic supplementation. To this end, we orally infected C57BL/6 mice with 10 T. gondii cysts and administered supplemental probiotics daily. We analyzed the levels of T. gondii B1 gene DNA, indicative of T. gondii infection, in brain tissue. We investigated alterations in the gut microbiota composition and functional pathways between the probiotic and non-probiotic treatment groups via next-generation sequencing analysis of each fecal sample. The infection level in the probiotic-treated group was significantly reduced after 4 weeks (P<0.05). Probiotic supplementation notably changed the gut microbiota after 2 weeks of infection, increasing the relative abundance of Intestinimonas massiliensis and Lawsonibacter asaccharolyticus. Probiotic supplements appear to modulate the gut microbiota, activating functional pathways involved in intestinal short-chain fatty acid production and strengthening the intestinal barrier, thereby impeding T. gondii infection and subsequent proliferation. Our findings provide valuable insights into T. gondii infection control and future study directions.
참고문헌 (35)
- Scallan E, "Foodborne illness acquired in the United States—major pathogens", Emerg Infect Dis, 17(1), pp.7~ (2011)[DOI]
- Kortbeek LM, "Congenital toxoplasmosis and DALYs in the Netherlands", Mem. Inst. Oswaldo Cruz, 104(2), pp.370~373 (2009)[DOI]
- Blader IJ, "Lytic cycle of Toxoplasma gondii : 15 years later", Annu Rev Microbiol, 69, pp.463~485 (2015)[DOI]
- Feustel SM, "Toxoplasma gondii and the blood-brain barrier", Virulence, 3(2), pp.182~192 (2012)[DOI]
- Matta SK, "Toxoplasma gondii infection and its implications within the central nervous system", Nat Rev Microbiol, 19(7), pp.467~480 (2021)[DOI]
- Atmaca LS, "Clinical features and prognosis in ocular toxoplasmosis", Jpn J Ophthalmol, 48, pp.386~391 (2004)[DOI]
- Sutterland AL, "Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and metaanalysis", Acta Psychiatr Scand, 132(3), pp.161~179 (2015)[DOI]
- Dunay IR, "Treatment of toxoplasmosis : historical perspective, animal models, and current clinical practice", Clin Microbiol Rev, 31(4), pp.10~1128 (2018)[DOI]
- Snyder LM, "From initiators to effectors : roadmap through the intestine during encounter of Toxoplasma gondii with the mucosal immune system", Front Cell Infect Microbiol, 10, pp.614701~ (2021)[DOI]
- Partida-Rodríguez O, "Human intestinal microbiota : interaction between parasites and the host immune response", Arch Med Res, 48(8), pp.690~700 (2017)[DOI]
- Belkaid Y, "Role of the microbiota in immunity and inflammation", Cell, 157(1), pp.121~141 (2014)[DOI]
- Yan X, "Study on the antagonistic effects of koumiss on Toxoplasma gondii infection in mice", Front Nutr, 9, pp.1014344~ (2022)[DOI]
- Kumar Bajaj B, "Functional mechanisms of probiotics", J Microbiol Biotechnol Food Sci, 4(4), pp.321~327 (2015)[DOI]
- Libertucci J, "The role of the microbiota in infectious diseases", Nat Microbiol, 4(1), pp.35~45 (2019)[DOI]
- Hiippala K, "The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation", Nutrients, 10(8), pp.988~ (2018)[DOI]
- Zhang Z, "Roles and applications of probiotic Lactobacillus strains", Appl Microbiol Biotechnol, 102, pp.8135~8143 (2018)[DOI]
- Segata N, "Metagenomic biomarker discovery and explanation", Genome Biol, 12(6) (2011)[DOI]
- Douglas GM, "PICRUSt2 for prediction of metagenome functions", Nat Biotechnol, 38(6), pp.685~688 (2020)[DOI]
- Rossi F, "Members of the Lactobacillus genus complex(LGC)as opportunistic pathogens : a review", Microorganisms, 7(5), pp.126~ (2019)[DOI]
- Speer CA, "Ultrastructure of early stages of infections in mice fed Toxoplasma gondii oocysts", Parasitology, 116(1), pp.35~42 (1998)[DOI]
- Chew WK, "Toxoplasma gondii : determination of the onset of chronic infection in mice and the in vitro reactivation of brain cysts", Exp Parasitol, 130(1), pp.22~25 (2012)[DOI]
- Mitsunaga T, "Infection dynamics of Toxoplasma gondii in gut-associated tissues after oral infection : the role of Peyer’s patches", Parasitol Int, 68(1), pp.40~47 (2019)[DOI]
- Benson A, "Gut commensal bacteria direct a protective immune response against Toxoplasma gondii", Cell Host Microbe, 6(2), pp.187~196 (2009)[DOI]
- Dubey JP, "Bradyzoite-induced murine toxoplasmosis : stage conversion, pathogenesis, and tissue cyst formation in mice fed bradvzoites of-different strains of Toxoplasma gondii", J Eukaryot Microbiol, 44(6), pp.592~602 (1997)[DOI]
- Wade H, "Akkermansia muciniphila and its membrane protein ameliorates intestinal inflammatory stress and promotes epithelial wound healing via CREBH and miR-143", 145, 2023, pp.30(1), 38~
- Lück R, "Genetic tools for the redirection of the central carbon flow towards the production of lactate in the human gut bacterium Phocaeicola(Bacteroides)vulgatus", Appl Microbiol Biotechnol, 106(3), pp.1211~1225 (2022)[DOI]
- Meng JX, "Metagenomic insights into the composition and function of the gut microbiota of mice infected with Toxoplasma gondii", Front Immunol, 14, pp.1156397~ (2023)
- Afouda P, "Noncontiguous finished genome sequence and description of Intestinimonas massiliensis sp. nov strain GD 2T, the second Intestinimonas species cultured from the human gut", Microbiologyopen, 8(1), pp.e00621~ (2019)[DOI]
- Markowiak-Kopeć P, "The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome", Nutrients, 12(4), pp.1107~ (2020)[DOI]
- Tong LC, "Propionate ameliorates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress", Front Pharmacol, 7, pp.253~ (2016)[DOI]
- Jiang L, "Sodium butyrate alleviates lipopolysaccharide-induced inflammatory responses by down-regulation of NF-κB, NLRP3 signaling pathway, and activating histone acetylation in bovine macrophages", Front Vet Sci, 7, pp.579674~ (2020)[DOI]
- Mahamed DA, "CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system", Proc Natl Acad Sci USA, 109(40), pp.16312~16317 (2012)[DOI]
- Liang L, "Gut microbiotaderived butyrate regulates gut mucus barrier repair by activating the macrophage", WNT, Clin Sci, pp.2022, 136(4)[DOI]
- Feng C, "Microbiota-derived short chain fatty acids : their role and mechanisms in viral infections", Biomed Pharmacother, 160, pp.114414~ (2023)[DOI]
- Fotidis IA, "Effect of ammonium and acetate on methanogenic pathway and methanogenic community composition", FEMS Microbiol Ecol, 83(1), pp.38~48 (2013)[DOI]
